Article Details
Retrieved on: 2022-05-29 19:28:01
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Renaissance Technologies LLC now owns 133,400 shares of the biopharmaceutical company's stock valued at $40,000 after acquiring an additional 111,100 ...
Article found on: www.defenseworld.net
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here